Genomics and sequencing approach for identification of biomarkers to assess the efficacy of TGF-βRI inhibitors (of liver cancer) in vivo
3551 days ago
Liver cancer is third leading cause of deaths and fourth most frequent occuring cance...biomarker thats check the effects of inhibitor on signaling pathway underlying liver cancer....